Showing 1741-1750 of 4064 results for "".
Study Examines Cases of Abnormal Prenatal Testing Results and Subsequent Diagnosis of Maternal Cancer
https://reachmd.com/programs/the-jama-report/study-examines-cases-abnormal-prenatal-testing-results-and-subsequent-diagnosis-maternal-cancer/7636/[Read the Article] An increasing number of pregnant women are undergoing noninvasive prenatal testing to help identify fetal genetic abnormalities. This is done using a blood test that looks at the DNA of both the mother and fetus. In a small percentage of these tests, the results appear abnormal, bSAD: Treating Winter's Doldrums
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/sad-treating-winters-doldrums/4244/Winter is here, and for many that means seasonal depression. But how does it differ from other conditions like major depression and bipolar disorder?Waterpipe Smoking Trends Among Adolescents
https://reachmd.com/programs/clinicians-roundtable/waterpipe-smoking-trends-among-adolescents/3296/We recognize that tobacco use kills millions of people around the world each year, but most of the available research focuses on cigarette smoking. The scope of tobacco use extends well beyond cigarettes, and includes an upswing in hookah, or water pipe, smoking, which many young people believe is lThe Spread of HIV Through Sexual Violence Against Women
https://reachmd.com/programs/clinicians-roundtable/the-spread-of-hiv-through-sexual-violence-against-women/3252/Women around the world are more likely to be infected with HIV, in part because of their social and economic vulnerability. The stark lack of empowerment of women in many parts of the world indicates the need for men to help protect their gender counterparts from the scourge of HIV. Stephen Lewis, cEmory/ Georgia Tech Predictive Health Institute
https://reachmd.com/programs/clinicians-roundtable/emory-georgia-tech-predictive-health-institute/2318/The Emory/Georgia Tech Predictive Health Institute is building a new model of healthcare based on advances in science, technology and translational research combined with health economics, public policy, business and ethics. In this segment, host, Dr. Danny Petrasek speaks with the Institute's DireAdvances in IgAN: New Frontiers in Biomarkers and Treatment
https://reachmd.com/programs/frontlines-iga-nephropathy/advances-in-igan-new-frontiers-in-biomarkers-and-treatment/26944/How can understanding the pathogenesis of IgA nephropathy lead to targeted therapies that slow disease progression? Tune in to find out.Can We Prevent Psoriatic Arthritis Before Diagnosis?
https://reachmd.com/programs/living-rheum/prevent-psoriatic-arthritis-before-diagnosis/51050/As our understanding of psoriatic arthritis deepens, we're starting to turn our attention toward intervention: preventing the disease before it progresses or is officially diagnosed. Tune in to hear Dr. Laura Coates discuss the evolving landscape of psoriatic arthritis prevention and interception, iEmerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://reachmd.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
https://reachmd.com/programs/neurofrontiers/diagnosing-treating-neurocognitive-disorders-in-the-psychiatric-setting/15385/How can we accurately diagnose neurocognitive disorders? Tune in to this recap from the 2023 American Psychiatric Association Annual Meeting.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
https://reachmd.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.